Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Neurology

The Genetics and Biology of Episodic Ataxia

At a Glance

Hereditary Episodic Ataxia (EA) is a neurological disorder caused by genetic mutations, primarily in the KCNA1 or CACNA1A genes, that disrupt the brain's electrical signals. It is an autosomal dominant condition, meaning a person with EA has a 50% chance of passing it to each child.

To understand Hereditary Episodic Ataxia (EA), it helps to look at the “wiring” of your brain. Your brain and nerves communicate using tiny electrical signals. When the genes responsible for managing these signals contain an error, the result is a channelopathy—a disorder of the microscopic “gates” that control the flow of electricity in your body [1][2].

The Biology of “Leaky Gates”

Your nerve cells are covered in ion channels, which are specialized protein gates [3]. These gates open and close to let charged particles (ions like potassium and calcium) in and out of the cell. This movement creates the electrical currents that allow your brain to tell your legs to walk or your eyes to focus [4].

In EA, these gates are either “leaky,” get stuck, or don’t open enough [2]. This ion channel dysfunction primarily affects the cerebellum, the part of the brain that acts as your internal GPS and coordination center [5]. When the electricity in the cerebellum becomes unstable, it causes the temporary “glitches” in movement we call ataxia attacks [1].

The Two Main Genes: KCNA1 and CACNA1A

Most cases of EA are linked to one of two specific genes, each affecting a different type of electrical “gate.”

KCNA1 (Episodic Ataxia Type 1)

This gene provides instructions for a potassium channel. In EA1, a mutation alters how the gate functions, meaning it cannot properly reset the nerve after it fires [6][7].

  • In the brain: This leads to nerves firing too easily, disrupting coordination [8].
  • In the muscles: These same leaky gates are present in the nerves that control your muscles. This causes myokymia—the continuous, fine rippling of muscle fibers often seen in EA1 [9].

CACNA1A (Episodic Ataxia Type 2)

This gene builds a calcium channel that is vital for releasing chemical messengers between brain cells [10]. In EA2, the mutation reduces the amount of calcium that can enter the cell [11]. This specifically slows down the stabilizing signals in the cerebellum, allowing for long-lasting episodes of vertigo and imbalance [12][13].

One Gene, Multiple Conditions

The CACNA1A gene is particularly complex because different types of mutations in the same gene can lead to different—but often overlapping—conditions [10]:

  • FHM1 (Familial Hemiplegic Migraine type 1): Often caused by mutations that leave the gates open too long, leading to migraines with temporary one-sided weakness [14].
  • SCA6 (Spocerebellar Ataxia type 6): Usually caused by a “repeat expansion” (a repetitive section of DNA that gets too long), leading to a slow, progressive coordination loss rather than sudden episodes [14][15].
  • Overlap: Because these conditions share the same gene, it is common for a person with EA2 to also experience severe migraines or, over decades, develop some permanent coordination changes [16][17].

How EA is Inherited

Episodic Ataxia follows an autosomal dominant inheritance pattern [18].

  • Autosomal: The gene is not on a sex chromosome, so it affects men and women equally [18].
  • Dominant: You only need one copy of the mutated gene (from one parent) to have the condition. A person with EA has a 50% chance of passing the mutated gene to each child [18].

In some cases, a person may be the first in their family to have the mutation; this is called a de novo mutation [19].

The Importance of Genetic Counseling

Because EA carries a 50% inheritance risk, you should explicitly request a referral to a genetic counselor. A counselor will help you navigate the emotional and practical steps of family planning, and discuss whether and when extended family members should be offered testing [1].

Common questions in this guide

What does it mean that episodic ataxia is a channelopathy?
A channelopathy means there is a problem with the microscopic gates, or ion channels, that control electrical signals in your brain and nerves. In episodic ataxia, these gates do not open or close properly, leading to temporary coordination glitches.
What is the difference between EA1 and EA2 genes?
EA1 is typically caused by a mutation in the KCNA1 gene, which affects potassium channels and often causes continuous muscle rippling. EA2 is caused by a mutation in the CACNA1A gene, which affects calcium channels and typically causes longer attacks of imbalance and vertigo.
What are the chances of passing episodic ataxia to my children?
Episodic ataxia follows an autosomal dominant inheritance pattern. This means you only need one copy of the mutated gene to have the disorder, and there is a 50 percent chance of passing it to each of your children.
Can a CACNA1A gene mutation cause other neurological conditions?
Yes, different mutations in the CACNA1A gene can cause other conditions, such as familial hemiplegic migraine (FHM1) or spinocerebellar ataxia type 6 (SCA6). It is common for people with EA2 to also experience severe migraines or develop long-term coordination changes.
Why do I need to see a genetic counselor for episodic ataxia?
A genetic counselor helps you understand your specific genetic test results and what they mean for your health. They also guide you through the emotional and practical steps of family planning and help decide if your extended family members should be tested.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific mutation was found in my genetic testing, and what does it mean for my treatment?
  2. 2.Does my specific mutation in the CACNA1A gene put me at risk for other conditions like FHM1 or SCA6 later in life?
  3. 3.Given that this is autosomal dominant, can you refer me to a genetic counselor to discuss family planning?
  4. 4.How does my specific mutation respond to medications based on current research?
  5. 5.Are there any 'environmental triggers' that typically affect patients with my specific gene mutation more than others?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches.

    Hassan A

    Tremor and other hyperkinetic movements (New York, N.Y.) 2023; (13()):9 doi:10.5334/tohm.747.

    PMID: 37008993
  2. 2

    Targeting Ion Channels and Purkinje Neuron Intrinsic Membrane Excitability as a Therapeutic Strategy for Cerebellar Ataxia.

    Huang H, Shakkottai VG

    Life (Basel, Switzerland) 2023; (13(6)) doi:10.3390/life13061350.

    PMID: 37374132
  3. 3

    Lipids shape brain function through ion channel and receptor modulations: physiological mechanisms and clinical perspectives.

    Incontro S, Musella ML, Sammari M, et al.

    Physiological reviews 2025; (105(1)):137-207 doi:10.1152/physrev.00004.2024.

    PMID: 38990068
  4. 4

    From non-excitable single-cell to multicellular bioelectrical states supported by ion channels and gap junction proteins: Electrical potentials as distributed controllers.

    Cervera J, Pai VP, Levin M, Mafe S

    Progress in biophysics and molecular biology 2019; (149()):39-53 doi:10.1016/j.pbiomolbio.2019.06.004.

    PMID: 31255702
  5. 5

    Ion channelopathies to bridge molecular lesions, channel function, and clinical therapies.

    Carbone E, Mori Y

    Pflugers Archiv : European journal of physiology 2020; (472(7)):733-738 doi:10.1007/s00424-020-02424-y.

    PMID: 32607810
  6. 6

    Episodic ataxia type 2 (EA2) with interictal myokymia and focal dystonia.

    Nielsen EN, Ásbjörnsdóttir B, Møller LB, et al.

    Cold Spring Harbor molecular case studies 2022; (8(6)) doi:10.1101/mcs.a006236.

    PMID: 36307210
  7. 7

    A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions.

    Imbrici P, Altamura C, Gualandi F, et al.

    Molecular and cellular neurosciences 2017; (83()):6-12 doi:10.1016/j.mcn.2017.06.006.

    PMID: 28666963
  8. 8

    Dominant-negative mutation p.Arg324Thr in KCNA1 impairs Kv1.1 channel function in episodic ataxia.

    Tristán-Clavijo E, Scholl FG, Macaya A, et al.

    Movement disorders : official journal of the Movement Disorder Society 2016; (31(11)):1743-1748 doi:10.1002/mds.26737.

    PMID: 27477325
  9. 9

    Electrodiagnostic Assessment of Hyperexcitable Nerve Disorders.

    Hutto SK, Harrison TB

    Neurologic clinics 2021; (39(4)):1083-1096 doi:10.1016/j.ncl.2021.06.009.

    PMID: 34602216
  10. 10

    The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature.

    Indelicato E, Nachbauer W, Karner E, et al.

    European journal of neurology 2019; (26(1)):66-e7 doi:10.1111/ene.13765.

    PMID: 30063100
  11. 11

    Epilepsy and episodic ataxia type 2: family study and review of the literature.

    Verriello L, Pauletto G, Nilo A, et al.

    Journal of neurology 2021; (268(11)):4296-4302 doi:10.1007/s00415-021-10555-0.

    PMID: 33983550
  12. 12

    A novel mutation in CACNA1A gene in a Saudi female with episodic ataxia type 2 with no response to acetazolamide or 4-aminopyridine.

    Algahtani H, Shirah B, Algahtani R, et al.

    Intractable & rare diseases research 2019; (8(1)):67-71 doi:10.5582/irdr.2018.01133.

    PMID: 30881862
  13. 13

    Impact of 4-aminopyridine on vestibulo-ocular reflex performance.

    I Gusti Bagus M, Gordy C, Sanchez-Gonzalez R, et al.

    Journal of neurology 2019; (266(Suppl 1)):93-100 doi:10.1007/s00415-019-09452-4.

    PMID: 31270663
  14. 14

    Pearls & Oy-sters: Fatal brain edema is a rare complication of severe CACNA1A-related disorder.

    Gauquelin L, Hawkins C, Tam EWY, et al.

    Neurology 2020; (94(14)):631-634 doi:10.1212/WNL.0000000000009223.

    PMID: 32170034
  15. 15

    Adult-onset ataxia or developmental disorder with seizures: two sides of missense changes in CACNA1A.

    Balck A, Hanssen H, Hellenbroich Y, et al.

    Journal of neurology 2017; (264(7)):1520-1522 doi:10.1007/s00415-017-8494-z.

    PMID: 28455667
  16. 16

    Phenotypic variability in cases with CACNA1A mutation.

    Bozkaya-Yilmaz S, Olgac-Dundar N, Aliyeva N, et al.

    European journal of pediatrics 2025; (184(4)):261 doi:10.1007/s00431-025-06062-3.

    PMID: 40111503
  17. 17

    Episodic ataxia and SCA6 within the same family due to the D302N CACNA1A gene mutation.

    Pradotto L, Mencarelli M, Bigoni M, et al.

    Journal of the neurological sciences 2016; (371()):81-84 doi:10.1016/j.jns.2016.10.029.

    PMID: 27871455
  18. 18

    Episodic Ataxia Secondary to CEP290 Compound Heterozygous Mutations: A Case Report.

    Hamed M, Shetty A, Dzwiniel T, et al.

    Movement disorders clinical practice 2020; (7(1)):104-106 doi:10.1002/mdc3.12872.

    PMID: 31970223
  19. 19

    Genetic paroxysmal neurological disorders featuring episodic ataxia and epilepsy.

    Amadori E, Pellino G, Bansal L, et al.

    European journal of medical genetics 2022; (65(4)):104450 doi:10.1016/j.ejmg.2022.104450.

    PMID: 35219921

This page explains the genetics and inheritance of episodic ataxia for educational purposes only. Always consult a genetic counselor or neurologist regarding your specific genetic test results and family planning.

Get notified when new evidence is published on Hereditary episodic ataxia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.